Prednisone Active Not Recruiting Phase 2 Trials for Stage IV Prostate Adenocarcinoma / Hormone-Resistant Prostate Cancer / Recurrent Prostate Carcinoma / Metastatic Hormone Refractory Prostate Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02844582Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
NCT01503229Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer